Structure |
Chemical Name |
CAS |
MF |
|
Trelagliptin Impurity 17 |
865759-02-0 |
C17H20BrFN4O2 |
|
Dapoxetine Impurity 1 |
2825577-69-1 |
|
|
Regorafenib Impurity 15 |
|
|
|
Varenicline Impurity 2 |
|
|
|
Topiroxostat Impurity 5 |
|
|
|
Everolimus Impurity 5 |
|
|
|
Ibrutinib Impurity 3 |
|
|
|
Canagliflozin Impurity 9 |
|
|
|
Clopidogrel Impurity 14 |
|
C15H14ClNO2S |
|
Febuxostat Impurity 53 |
|
|
|
Cefodizime Impurity C |
|
|
|
Isavuconazole Impurity 39 |
207224-73-5 |
C21H18F2N4OS |
|
Isavuconazole Impurityi45 |
|
|
|
Gatifloxacinacid |
121577-32-0 |
C19H22FN3O4.ClH |
|
Bisoprolol Impurity 41 |
|
|
|
1,4-Naphthalenedione, 2-(3-hydroxy-3,7,11,15-tetramethyl-1,6,10,14-hexadecatetraenyl)-3-methyl-, (,E,E)- (9CI) |
65061-22-5 |
C31H40O3 |
|
Piperacilin |
|
|
|
Varenicline Impurity D |
1002359-81-0 |
|
|
2-Propanone, 1-(2-hydroxypropoxy)- (9CI) |
90817-38-2 |
C6H12O3 |
|
Nirmatrelvir Impurity 4 |
|
|
|
Nifedipine Impurity L |
|
|
|
2-Pyrrolidinone, 3,4-dihydroxy-5-(hydroxymethyl)-, (3R,4R,5R)- (9CI) |
155102-96-8 |
C5H9NO4 |
|
Bumetanide Impurity 24 |
|
|
|
Rocuronium Bromide Impurity 37、38、39 |
|
|
|
Ritonavir EP Impurity HIJ |
|
|
|
Crisaborole Impurity 42 |
|
|
|
Perospirone Impurity 26 |
|
|
|
Paxlovid Impurity 15 |
|
|
|
3-(2-(cyclopent-2-en-1-yl)-2-hydroxy-2-phenylacetoxy)-1,1-dimethylpyrrolidin-1-ium bromide |
|
|
|
Canagliflozin Impurity 84 |
|
|
|
Fondaparinux sodium impurity 18 |
|
|
|
Fondaparinux sodium impurity 13 |
|
|
|
Lasmiditan Impurity 1 |
|
|
|
(5R,6R)-6-((R)-1-hydroxyethyl)-3-((R)-tetrahydrofuran-2-yl)-4-thia-1-azabicyclo[3.2.0]hept-2-en-7-one |
|
|
|
Olodaterol Impurity 22 |
|
|
|
Olodaterol Impurity 25 |
|
|
|
32,43,50-Tricarboxy-cyanoco balamin |
|
|
|
(S)-Azelastine |
143228-85-7 |
C22H24ClN3O |
|
Relugolix Impurity 92 |
|
|
|
N-Desethyl Vardenafil |
448184-46-1 |
C21H28N6O4S |
|
O-デスメチルゲフィチニブ |
847949-49-9 |
C21H22ClFN4O3 |
|
N-デメチルシルデナフィルピラゾール |
139755-95-6 |
C21H28N6O4S |
|
S-(-)-Tolterodine |
124937-53-7 |
C22H31NO |
|
ゾルミトリプタンN-オキシド |
251451-30-6 |
C16H21N3O3 |
|
3-(hydroxymethyl)-9-methyl-1,2,3,9-tetrahydro-4H-carbazol-4-one |
|
|
|
7-CHLORO-1,3DIHYDRO-5-FLUOROPHENYL-2-NITRO-METHYLENE-2H-1,4-BENZODIAZEPINE-4-OXIDE |
60656-76-0 |
C16H11ClFN3O3 |
|
(1R,3aS,3bS,11aS)-1-ヒドロキシ-11a-メチル-1H,2H,3H,3aH,3bH,4H,5H,7H,8H,9H,11aH-シクロペンタ[a]フェナントレン-7-オン |
80657-17-6 |
C18H22O2 |
|
2-デオキシテトロン酸 |
1518-61-2 |
C4H8O4 |
|
シクロ[L-Abu-Sar-N-メチル-L-Leu-L-Val-N-メチル-L-Leu-L-Ala-D-Ala-N-メチル-L-Leu-N-メチル-L-Leu-N-メチル-L-Val-[(3R,4R)-3-ヒドロキシ*-N-メチル-5-[(E)-1-プロペニル]-L-Leu-]] |
59865-16-6 |
C62H111N11O12 |
|
GINKGOLIC ACIDS |
|
|
|
(R)-ズロキセチン塩酸塩 |
910138-96-4 |
C18H20ClNOS |
|
(R)-テラゾシン |
109351-34-0 |
C19H25N5O4 |
|
(1S,4R)-4-アミノ-2-シクロペンテン-1-カルボン酸メチル |
138923-03-2 |
C7H11NO2 |
|
L-Alanine,propylester(9CI) |
58989-06-3 |
C6H13NO2 |
|
N-hydroxyphenetidine |
38246-95-6 |
|
|
1-エチル-3-カルボキシ-6-フルオロ-1,4-ジヒドロ-7-(4-メチルピペラジノ)-4-オキソキノリン1-オキシド |
85145-21-7 |
C17H20FN3O4 |
|
2,3-ジメチル-1,4-ナフトキノン |
2197-57-1 |
C12H10O2 |
|
Rosuvastatin Impurity 145 |
|
|
|
Peramivir Intermediate impurity 1 |
|
|
|
Rosuvastatin EP Impurity G |
|
|
|
Peramivir Intermediate Impurity 43 |
|
|
|
Peramivir Deacetylated Impurity |
|
|
|
Linagliptin Impurity 49 |
|
|
|
Solifenacin Related CoMpound 2 Succinate |
1262506-09-1 |
C27H32N2O6 |
|
Tetrahydro FuroseMide |
4793-38-8 |
C12H15ClN2O5S |
|
6-O-DesMethoxyethyl-6-O-chloroethyl Erlotinib Hydrochloride |
183320-04-9 |
C21H21Cl2N3O3 |
|
Macitentan IMpurity |
556796-88-4 |
C17H15Br2N5O4S |
|
4-((4-broMophenyl)(1H-1,2,4-triazol-1-yl)Methyl)benzonitrile |
143030-54-0 |
C16H11BrN4 |
|
Acetic acid, 2-[2-[4-(diphenylMethyl)-1-piperazinyl]ethoxy]- |
83881-53-2 |
C21H26N2O3 |
|
Benazepril Related CoMpound B |
|
|
|
IMatinib iMpurity |
152459-96-6 |
C24H21N5O |
|
(2R,3R,4R,5S,6R)-2-(acetoxyMethyl)-6-(3-((5-(4-fluorophenyl)thiophen-2-yl)Methyl)-4-Methylphenyl)tetrahydro-2H-pyran-3,4,5-triyl triacetate |
|
C32H33FO9S |
|
1,2-BenzenedicarboxaMide, N1,N2-bis[[(5S)-2-oxo-3-[4-(3-oxo-4-Morpholinyl)phenyl]-5-oxazolidinyl]Methyl]- |
1365267-36-2 |
C36H36N6O10 |
|
(4-メチルキナゾリン-2-イル)メタノール |
13535-91-6 |
C10H10N2O |
|
5-(2,2-diMethyl-4H-benzo[d][1,3]dioxin-6-yl)oxazolidin-2-one |
452340-96-4 |
C13H15NO4 |
|
alpha-(Dimethylaminomethyl)-alpha-ethylbenzyl alcohol hydrochloride |
104743-23-9 |
C12H20ClNO |
|
N-[6,9-Dihydro-6-oxo-9-[[2-(1-oxopropoxy)-1-[(1-oxopropoxy)methyl]ethoxy]methyl]-1H-purin-2-yl]propanamide |
177216-32-9 |
C18H25N5O7 |
|
5-Bromo-1-(4-fluorophenyl)-1,3-dihydro-N,N-dimethyl-1-isobenzofuranpropanamine ethanedioate (1:1) |
64372-43-6 |
C21H23BrFNO5 |
|
(E)-2-Methyl-4-(4-(2-Methyl-5,10-dihydro-4H-benzo[b]thieno[2,3-e][1,4]diazepin-4-yl)piperazin-1-yl)-10H-benzo[b]thieno[2,3-e][1,4]diazepine |
1070876-09-3 |
C28H26N6S2 |
|
(1S,2S,3R,5S)-PinanediolN-BOC-L-phenylalanine-L-leucine boronate |
1187479-72-6 |
C29H45BN2O5 |
|
Posaconazole iMpurity 7 |
2180759-84-4 |
C37H42F2N8O4 |
|
Intedanib Impurity |
2243396-74-7 |
C31H32N6O6 |
|
Donepezil Impurity 3 |
1023500-88-0 |
C24H27NO4 |
|
Fesoterodine Related Impurity 4 |
214601-12-4 |
C22H29NO2 |
|
Prasugrel Impurity 14 Maleate |
1373350-60-7 |
C24H25BrFNO7S |
|
Sofosbuvir Impurity 32 |
1157884-58-6 |
C20H17FO6 |
|
Torsemide Related Compound 1 |
947327-54-0 |
C13H13N3O2S |
|
Vortioxetine Impurity 3 |
508233-82-7 |
C17H20N2S |
|
CYCLOPENTYL BENZOATE |
32651-38-0 |
C12H14O2 |
|
4,5-ジクロロチオフェン-2-カルボン酸 |
31166-29-7 |
C5H2Cl2O2S |
|
N,O-Dibenzylated formoterol |
43229-70-5 |
C33H36N2O4 |
|
Entacapone |
|
|
|
nifedipine iMpurity |
|
C19H22N2O6 |
|
Linagliptin Impurity A |
|
|
|
Dehydropitavastatin ethyl ester |
254452-91-0 |
C27H26FNO4 |
|
(S)-2-(2-oxo-4-propyl-2,5-dihydro-1H-pyrrol-1-yl)butanamide |
357338-13-7 |
C11H18N2O2 |
|
Linagliptin Impurity V |
|
|
|
methyl 2-(4-(2-chloroethyl)phenyl)-2-methylpropanoate |
1181267-33-3 |
C13H17ClO2 |
|
(2RS)-1-bromo-2-(2,4-difluorophenyl)-3-(1H-1,2,4-triazol-1-yl)propan-2-ol |
150194-52-8 |
C11H10BrF2N3O |
|
(S)-2-(((1R,2S,5S)-2-(2-((5-chloropyridin-2-yl)amino)-2-oxoacetamido)-5-(dimethylcarbamoyl)cyclohexyl)carbamoyl)-5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine 5-oxide |
|
C24H30ClN7O5S |